Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.

Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.

SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment of amyotrophic lateral sclerosis (ALS) has officially initiated...

Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer

Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer

– Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naive patients with differentiated thyroid cancer – TOKYO, Oct. 31, 2025 /PRNewswire/ -- Alpha Fusion Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Sunao Fujioka;...

SilentSwap V2 Launch Sets New Standard for Institutional Blockchain Privacy Infrastructure

SilentSwap V2 Launch Sets New Standard for Institutional Blockchain Privacy Infrastructure

SilentSwap V2 introduces a privacy-focused infrastructure designed for organizations deploying blockchain technology. Recognizing that over 70% of institutions cite privacy as a major barrier to adoption, SilentSwap V2 addresses transparency risks...

AI Semiconductor Innovator DEEPX Recognized by NYSE and WEF

AI Semiconductor Innovator DEEPX Recognized by NYSE and WEF

The Leading Player in On-Device AI Is Realizing the Physical AI Era While Drawing Wall Street's Attention NEW YORK, Oct. 31, 2025 /PRNewswire/ -- As AI begins to sustainably generate tangible value, global AI semiconductor innovator DEEPX (CEO...

Elevaris Medical Devices Names New Chief Engineering and Operations Officer

Elevaris Medical Devices Names New Chief Engineering and Operations Officer

BOSTON, Oct. 31, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract Development and Manufacturing Organization for industry-leading multi-national healthcare companies, announced the appointment of its new Chief Engineering and Operations...

SuperX Digital Power Launches Flagship "Panama + Aurora" Full-Chain 800VDC Power Solutions -- Dual-Path Breakthrough for Data Center Power Bottlenecks

SuperX Digital Power Launches Flagship "Panama + Aurora" Full-Chain 800VDC Power Solutions -- Dual-Path Breakthrough for Data Center Power Bottlenecks

SINGAPORE, Oct. 31, 2025 /PRNewswire/ -- SuperX AI Technology Limited (NASDAQ: SUPX) ("the Company" or "SuperX"), a provider of full-stack AI infrastructure solutions, today announced that its joint venture with Zhonhen Electric Co., Ltd....

Yalla Group Limited to Report Third Quarter 2025 Financial Results on November 10, 2025 Eastern Time

Yalla Group Limited to Report Third Quarter 2025 Financial Results on November 10, 2025 Eastern Time

DUBAI, UAE, Oct. 31, 2025 /PRNewswire/ -- Yalla Group Limited ("Yalla" or the "Company") (NYSE: YALA), the largest Middle East and North Africa (MENA)-based online social networking and gaming company, today announced that it will report its...

Pioneering Nuclear Fusion Energy Innovation for Two Decades: Shanghai Electric Empowers Global CRAFT and ITER Projects, Driving a Sustainable Future for Earth

Pioneering Nuclear Fusion Energy Innovation for Two Decades: Shanghai Electric Empowers Global CRAFT and ITER Projects, Driving a Sustainable Future for Earth

China's Leading High-End Equipment Manufacturer Advances International Cooperation in Nuclear Fusion Energy SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Electric (SEHK: 2727, SSE: 601727) has recently announced several key milestones in the...

JW Therapeutics and Regeneron Expand Strategic Collaboration Agreement to Advance TCR-T Cell Therapy Development and Maximize Global Platform Potential

JW Therapeutics and Regeneron Expand Strategic Collaboration Agreement to Advance TCR-T Cell Therapy Development and Maximize Global Platform Potential

SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the execution of an Amendment...

Fox ESS and OSW Ink Strategic Partnership for 2GWh Energy Storage Projects at All Energy 2025

Fox ESS and OSW Ink Strategic Partnership for 2GWh Energy Storage Projects at All Energy 2025

MELBOURNE, Australia, Oct. 31, 2025 /PRNewswire/ -- Fox ESS, a leading provider of renewable energy solutions, has officially announced a strategic partnership with OSW, Australia's premier solar wholesaler and distributor. The two companies have...

  • 1
  • ...
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • ...
  • 165
  • menu
    menu